Read More Pharma Industry News Vistagen shares topline PALISADE-3 Phase 3 data for fasedienol in acute social anxiety treatment Find out how Vistagen’s PALISADE-3 Phase 3 results for fasedienol reshape its social anxiety strategy and investor expectations. bySoujanya RaviDecember 17, 2025